Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Epidemiological studies consistently show that circulating sex hormone binding globulin (SHBG) levels are lower in type 2 diabetes patients than non-diabetic individuals, but the causal nature of this association is controversial. Genetic studies can help dissect causal directions of epidemiological associations because genotypes are much less likely to be confounded, biased or influenced by disease processes. Using this Mendelian randomization principle, we selected a common single nucleotide polymorphism (SNP) near the SHBG gene, rs1799941, that is strongly associated with SHBG levels. We used data from this SNP, or closely correlated SNPs, in 27 657 type 2 diabetes patients and 58 481 controls from 15 studies. We then used data from additional studies to estimate the difference in SHBG levels between type 2 diabetes patients and controls. The SHBG SNP rs1799941 was associated with type 2 diabetes [odds ratio (OR) 0.94, 95% CI: 0.91, 0.97; P = 2 x 10(-5)], with the SHBG raising allele associated with reduced risk of type 2 diabetes. This effect was very similar to that expected (OR 0.92, 95% CI: 0.88, 0.96), given the SHBG-SNP versus SHBG levels association (SHBG levels are 0.2 standard deviations higher per copy of the A allele) and the SHBG levels versus type 2 diabetes association (SHBG levels are 0.23 standard deviations lower in type 2 diabetic patients compared to controls). Results were very similar in men and women. There was no evidence that this variant is associated with diabetes-related intermediate traits, including several measures of insulin secretion and resistance. Our results, together with those from another recent genetic study, strengthen evidence that SHBG and sex hormones are involved in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“higher levels associated with reduced risk of type 2 diabetes [63], [64].”
From Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men (2012) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Particular single nucleotide polymorphisms (SNPs) for SHBG confer increased risk for T2D (102, 104).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · cited 1×
“Genetic studies can be a valuable additional tool which help to dissect causal directions of epidemiological associations (14).”
BackgroundVariant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“39, are similar to those for SNPs in the TCF7L2 gene (9), which raises doubt as to why these associations were not found by genome-wide association approaches, and the evidence of association between SHBG SNPs and type 2 diabetes was not strong (P 1⁄4 0.”
BackgroundWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864 · cited 1×
“12], all of European ancestry] (22), and this SNP appears to be less strongly associated with SHBG levels than rs1799941, based on data from previous studies (23,24).”
BackgroundSelf-citationDing, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
NILSSEN, O., FØRDE, O. H., & BRENN, T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115661 · Cited by 815
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A. U., Aulchenko, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.290 · Cited by 744 · cited 1×
“For measures of fasting glucose and homeostatic model assessment (HOMA) based measures of insulin resistance, we used data from MAGIC of between 36 135 and 45 691 individuals, details of which are described in detail elsewhere (31).”
Self-citationSex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726 · cited 3×
“02 for each SNP under the best model) (2).”
BackgroundInfluentialGudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723 · cited 1×
“Second, a SNP (rs6259) in the SHBG gene has been associated with prostate cancer and there is increasing evidence that there may be a casual link to the inverse association between prostate cancer and type 2 diabetes (27), although our results suggest that this requires additional studies of rs1799941 in prostate canc…”
ResultSelf-citationPasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635 · cited 1×
“Finally, insulin lowering interventions in non-diabetic men and women (without PCOS) lead to increased SHBG levels, suggesting that insulin can causally influence sex hormone dynamics (12,13).”
BackgroundThe effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
A genome-wide association study identifies protein quantitative trait loci (pQTLs)
Melzer, D., Perry, J. R. B., Hernandez, D., Corsi, A.-M., Stevens, K., Rafferty, I., Lauretani, F., Murray, A., Gibbs, J. R., Paolisso, G., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000072 · Cited by 480 · cited 3×
“12], all of European ancestry] (22), and this SNP appears to be less strongly associated with SHBG levels than rs1799941, based on data from previous studies (23,24).”
BackgroundSelf-citationRole of Endocytosis in Cellular Uptake of Sex Steroids
Hammes, A., Andreassen, T. K., Spoelgen, R., Raila, J., Hubner, N., Schulz, H., Metzger, J., Schweigert, F. J., Luppa, P. B., Nykjaer, A., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.032 · Cited by 413 · cited 1×
“However, there is recent evidence that bound testosterone may be biologically active (26).”
BackgroundBoyanov, M. A., Boneva, Z., & Christov, V. G. (2003) · The Aging Male · doi:10.1080/tam.6.1.1.7 · Cited by 381
Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
Dunning, A. M., Dowsett, M., Healey, C. S., Tee, L., Luben, R. N., Folkerd, E., Novik, K. L., Kelemen, L., Ogata, S., Pharoah, P. D. P., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh167 · Cited by 346 · cited 2×
“showed that the SHBG lowering allele at rs1799941 is not associated with total testosterone levels in postmenopausal women (N 1⁄4 1975) (23).”
BackgroundFreathy, R. M., Timpson, N. J., Lawlor, D. A., Pouta, A., Ben-Shlomo, Y., Ruokonen, A., Ebrahim, S., Shields, B., Zeggini, E., Weedon, M. N., et al. (2008) · Diabetes · doi:10.2337/db07-1466 · Cited by 316
Self-citationGrarup, N., Rose, C. S., Andersson, E. A., Andersen, G., Nielsen, A. L., Albrechtsen, A., Clausen, J. O., Rasmussen, S. S., Jørgensen, T., Sandbæk, A., et al. (2007) · Diabetes · doi:10.2337/db07-0856 · Cited by 260 · cited 1×
“For measures of insulin secretion, we used 5771 individuals from the Danish study, details of which are described in detail elsewhere (32).”
MethodSelf-citationPascoe, L., Tura, A., Patel, S. K., Ibrahim, I. M., Ferrannini, E., Zeggini, E., Weedon, M. N., Mari, A., Hattersley, A. T., McCarthy, M. I., et al. (2007) · Diabetes · doi:10.2337/db07-0634 · Cited by 254
Self-citationDunaif, A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80057-6 · Cited by 236 · cited 1×
“Third, hyper-androgenic disorders such as polycystic ovarian syndrome (PCOS) in women result in an increased risk of type 2 diabetes and are very strongly associated with insulin resistance (3).”
BackgroundPasquali, R., Casimirri, F., De Iasio, R., Mesini, P., Boschi, S., Chierici, R., Flamia, R., Biscotti, M., & Vicennati, V (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852532 · Cited by 215 · cited 1×
“Finally, insulin lowering interventions in non-diabetic men and women (without PCOS) lead to increased SHBG levels, suggesting that insulin can causally influence sex hormone dynamics (12,13).”
BackgroundSex Steroid Hormones, Upper Body Obesity, and Insulin Resistance
Abate, N., Haffner, S. M., Garg, A., Peshock, R. M., & Grundy, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020567 · Cited by 187
Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Lin, H.-Y., Xu, Q., Yeh, S., Wang, R.-S., Sparks, J. D., & Chang, C. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1717 · Cited by 172 · cited 1×
“Fourth, male rats lacking the androgen receptor are insulin resistant (7) and female rats treated with testosterone after oophorectomy become insulin resistant (8), findings that are consistent with the sex-specific associations seen in humans.”
BackgroundBrunner, E. J., Kivimäki, M., Witte, D. R., Lawlor, D. A., Smith, G. D., Cooper, J. A., Miller, M., Lowe, G. D. O., Rumley, A., Casas, J. P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050155 · Cited by 163 · cited 1×
“This ‘Mendelian randomization’ principle has been used recently in the context of metabolic traits to provide evidence that lifelong exposure to slightly raised C-reactive protein (CRP) (15), Interleukin-18 (IL18) (16), regulated on activation, normal T-cell expressed and secreted protein (RANTES) (17) or beta-caroten…”
BackgroundGrarup, N., Andersen, G., Krarup, N. T., Albrechtsen, A., Schmitz, O., Jørgensen, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2008) · Diabetes · doi:10.2337/db08-0436 · Cited by 157
Self-citationRincon, J., Holmäng, A., Wahlström, E. O., Lönnroth, P., Björntorp, P., Zierath, J. R., & Wallberg-Henriksson, H. (1996) · Diabetes · doi:10.2337/diab.45.5.615 · Cited by 149 · cited 1×
“Fourth, male rats lacking the androgen receptor are insulin resistant (7) and female rats treated with testosterone after oophorectomy become insulin resistant (8), findings that are consistent with the sex-specific associations seen in humans.”
BackgroundKalme, T., Seppälä, M., Qiao, Q., Koistinen, R., Nissinen, A., Harrela, M., Loukovaara, M., Leinonen, P., & Tuomilehto, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0762 · Cited by 142
Simon, D., Charles, M.-A., Lahlou, N., Nahoul, K., Oppert, J.-M., Gouault-Heilmann, M., Lemort, N., Thibult, N., Joubert, E., Balkau, B., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2149 · Cited by 136
Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype
Brennan, P., McKay, J., Moore, L., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp162 · Cited by 108 · cited 1×
“For example the association between variation in the FTO gene, that is associated with adiposity, and some cancers, provides some evidence that adiposity has an aetiological role in cancer (20).”
BackgroundPartial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control
Corrales, J. J., Burgo, R. M., Garcı́a-Berrocal, B., Almeida, M., Alberca, I., González-Buitrago, J. M., Orfao, A., & Miralles, J. M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.016 · Cited by 97
Herder, C., Klopp, N., Baumert, J., Müller‐Nurasyid, M., Khuseyinova, N., Meisinger, C., Martin, S., Illig, T., Köenig, W., & Thorand, B. (2007) · Diabetologia · doi:10.1007/s00125-007-0800-3 · Cited by 94 · cited 1×
“This ‘Mendelian randomization’ principle has been used recently in the context of metabolic traits to provide evidence that lifelong exposure to slightly raised C-reactive protein (CRP) (15), Interleukin-18 (IL18) (16), regulated on activation, normal T-cell expressed and secreted protein (RANTES) (17) or beta-caroten…”
BackgroundSelf-citationSvartberg, J. B., Jenssen, T. G., Sundsfjord, J., & Jorde, R. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70086-1 · Cited by 79
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
Berndt, S. I., Chatterjee, N., Huang, W.-Y., Chanock, S. J., Welch, R., Crawford, E. D., & Hayes, R. B. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0689 · Cited by 79 · cited 1×
“Second, a SNP (rs6259) in the SHBG gene has been associated with prostate cancer and there is increasing evidence that there may be a casual link to the inverse association between prostate cancer and type 2 diabetes (27), although our results suggest that this requires additional studies of rs1799941 in prostate canc…”
ResultLiu, P., Wishart, S., Celermajer, D., Jimenez, M., Pierro, I., Conway, A., & Handelsman, D. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480055 · Cited by 70 · cited 1×
“Studies in animals may not be relevant to humans and human trials of androgen therapy have focused on people with extreme levels of obesity or circulating hormones and conflicting results have been reported (10,11).”
ResultRafiq, S., Melzer, D., Weedon, M. N., Lango, H., Saxena, R., Scott, L. J., the DIAGRAM Consortium, Palmer, C. N. A., Morris, A. D., McCarthy, M. I., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1160-3 · Cited by 46 · cited 1×
“This ‘Mendelian randomization’ principle has been used recently in the context of metabolic traits to provide evidence that lifelong exposure to slightly raised C-reactive protein (CRP) (15), Interleukin-18 (IL18) (16), regulated on activation, normal T-cell expressed and secreted protein (RANTES) (17) or beta-caroten…”
BackgroundSelf-citationAhn, J., Schumacher, F. R., Berndt, S. I., Pfeiffer, R., Albanes, D., Andriole, G. L., Ardanaz, E., Boeing, H., Bueno-de-Mesquita, B., Chanock, S. J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp302 · Cited by 43 · cited 2×
“but previously published data (25) indicates that rs1799941 and rs6257 are partially correlated and that rs1799941 drives the association with SHBG levels.”
BackgroundResultHerder, C., Illig, T., Baumert, J., Müller‐Nurasyid, M., Klopp, N., Khuseyinova, N., Meisinger, C., Poschen, U., Martin, S., Köenig, W., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0686 · Cited by 39 · cited 1×
“This ‘Mendelian randomization’ principle has been used recently in the context of metabolic traits to provide evidence that lifelong exposure to slightly raised C-reactive protein (CRP) (15), Interleukin-18 (IL18) (16), regulated on activation, normal T-cell expressed and secreted protein (RANTES) (17) or beta-caroten…”
BackgroundSelf-citationThe Biological Variation of Sex Hormone-Binding Globulin in Type 2 Diabetes
Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Holding, S., Hepburn, D. A., & Atkin, S. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.278 · Cited by 34
Circulating β-carotene levels and type 2 diabetes—cause or effect?
the DIAGRAM Consortium, Perry, J. R. B., Ferrucci, L., Bandinelli, S., Guralnik, J., Semba, R. D., Rice, N., Melzer, D., Saxena, R., Scott, L. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1475-8 · Cited by 24
Self-citationDo Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat?
Stoney, R. M., Walker, K. Z., Best, J. D., Ireland, P. D., Giles, G. G., & O’Dea, K. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.828 · Cited by 20
A simple method for converting an odds ratio to effect size for use in meta-analysis
Chinn, S. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001130)19:22<3127::aid-sim784>3.0.co;2-m · cited 1×
“81 is the scaling factor used to approximate ln(ORs) to and from standardized mean differences (30).”
Method
Cited by
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Self-citationHepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
Understanding weight gain at menopause
Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P., & as the Writing Group of the International Menopause Society for World Menopause Day 2012 (2012) · Climacteric · doi:10.3109/13697137.2012.707385 · Cited by 604
Mendelian randomization studies: a review of the approaches used and the quality of reporting
Boef, A. G. C., Dekkers, O. M., & le Cessie, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv071 · Cited by 610
Metadata
- Authors
- Perry, J. R. B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., Paolisso, G., Walker, M., Palmer, C. N. A., Payne, F., Young, E., Herder, C., Narisu, N., Morken, M. A., Bonnycastle, L. L., Owen, K. R., Shields, B., Knight, B., Bennett, A., Groves, C. J., Ruokonen, A., Jarvelin, M. R., Pearson, E., Pascoe, L., Ferrannini, E., Bornstein, S. R., Stringham, H. M., Scott, L. J., Kuusisto, J., Nilsson, P., Neptin, M., Gjesing, A. P., Pisinger, C., Lauritzen, T., Sandbaek, A., Sampson, M., Zeggini, M., Lindgren, C. M., Steinthorsdottir, V., Thorsteinsdottir, U., Hansen, T., Schwarz, P., Illig, T., Laakso, M., Stefansson, K., Morris, A. D., Groop, L., Pedersen, O., Boehnke, M., Barroso, I., Wareham, N. J., Hattersley, A. T., McCarthy, M. I., & Frayling, T. M.
- Affiliations
- University of Exeter (GB)
- Addenbrooke's Hospital (GB)
- University of Michigan (US)
- Lund University (SE)
- Helmholtz Munich (DE)
- National Institutes of Health (US)
- University of Parma (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Newcastle University (GB)
- University of Dundee (GB)
- Wellcome Sanger Institute (GB)
- Deutsches Diabetes-Zentrum e.V. (DE)
- National Human Genome Research Institute (US)
- Churchill Hospital (GB)
- University of Pisa (IT)
- Technische Universität Dresden (DE)
- Kuopio University Hospital (FI)
- Glostrup Hospital (DK)
- Norfolk and Norwich University Hospital (GB)
- Centre for Human Genetics (GB)
- University of Southern Denmark (DK)
- University of Copenhagen (DK)
- Corresponding author
- Frayling, Timothy M.
- ORCID
- Perry, John R.B.
- Weedon, Michael N.
- Langenberg, Claudia
- Jackson, Anne U.
- Lyssenko, Valeriya
- Grallert, Harald
- Ferrucci, Luigi
- Maggio, Marcello
- Paolisso, Giuseppe
- Walker, Mark
- Payne, Felicity
- Herder, Christian
- Narisu, Narisu
- Bonnycastle, Lori L.
- Owen, Katharine R.
- Shields, Beverley
- Bennett, Amanda
- Pearson, Ewan
- Pascoe, Laura
- Ferrannini, Ele
- Bornstein, Stefan R.
- Stringham, Heather M.
- Scott, Laura J.
- Nilsson, Peter
- Neptin, Malin
- Gjesing, Anette P.
- Pisinger, Charlotta
- Lauritzen, Torsten
- Sampson, Mike
- Lindgren, Cecilia M.
- Hansen, Torben
- Schwarz, Peter
- Laakso, Markku
- Morris, Andrew D.
- Groop, Leif
- Pedersen, Oluf
- Boehnke, Michael
- Barroso, Inês
- Wareham, Nicholas J.
- Hattersley, Andrew T.
- McCarthy, Mark I.
- Frayling, Timothy M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-18
- Volume
- 19
- Issue
- 3
- Pages
- 535-544
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2798726
- OpenAlex
- W2139109527
- Cited by
- 217
- References
- 40
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 19 · 2020: 15 · 2019: 10 · 2018: 7 · 2017: 13 · 2016: 8 · 2015: 13 · 2014: 13 · 2013: 14 · 2012: 25
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Human Molecular Genetics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- American Diabetes Association
- Pfizer
- AstraZeneca (QLG1-CT-2001-01252)
- Hjerteforeningen
- Aarhus Universitet
- Sundhed og Sygdom, Det Frie Forskningsråd
- Wellcome Trust (083270, GR072960, 077016, 083270/Z/07/Z, 077016/Z/05/Z, 090532, 518153, 076113)
- National Institute for Health and Care Research (DHCS/07/07/008)
- Diabetes UK
- European Commission (QLG1-CT-2001-01252)
- Academy of Finland (124243)
- Bundesministerium für Bildung und Forschung
- Aarhus Universitets Forskningsfond
- Technische Universität Dresden
- Bundesministerium für Gesundheit
- Lundbeckfonden
- Novo Nordisk
- Augustinus Fonden
- Novo Nordisk Fonden
- Servier
- H. Lundbeck A/S
- Diabetesforeningen
- National Institutes of Health (DK062370)
- Medical Research Council (G0601261)
- Münchner Zentrum für Gesundheitswissenschaften
- National Institute on Aging (R01 AG 24233-01, R01 AG24233-0, R01AG24233, R01AG024233)
- National Institute on Drug Abuse (U54DA021519)
- National Human Genome Research Institute (Z01HG000024, HG000024)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-072193, R01DK072193, U01DK062370, R01DK069922, R56DK062370, DK069922, DK-062370, R01DK062370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- sex hormone-binding globulin, type 2 diabetes, SHBG gene, Mendelian randomization, causal inference, sex hormones, insulin secretion, insulin resistance, diabetes risk
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Risk Factors, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Case-Control Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.